Skip to content

Disposable Hyperbaric Oxygen Chamber

by Hospitak, Inc. 510(k)

Active United States

510(k) K840817

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK840817 Date25 Apr 1984ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 6 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
KPJ
Device Class
Class II
Regulation
21 CFR Part 878.5650
Advisory Committee
General, Plastic Surgery
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

This device is a disposable hyperbaric oxygen chamber, classified under Chamber, Oxygen, Topical, Extremity in regulatory nomenclature. It is designed to deliver hyperbaric oxygen therapy (HBOT) in a controlled, portable environment for localized treatment applications, enhancing oxygen delivery to targeted tissues.

The chamber is intended for single-use and is supplied as a medical device cleared under FDA 510(k) K840817 with a classification of Class II (Regulation 878.5650). It is intended for use in clinical settings such as general and plastic surgery, though its primary function is not tied to a specific clinical indication beyond hyperbaric oxygen delivery. No additional sterility or MRI safety information is provided in the specifications.

Other devices from Hospitak, Inc.

See all devices from Hospitak, Inc. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What clinical specialties is this disposable hyperbaric oxygen chamber primarily associated with, and how does that relate to its use?

    This chamber is associated with the General and Plastic Surgery specialties, as indicated by its regulatory filing under the SU (Skin and Soft Tissue) Advisory Committee. While it is cleared for hyperbaric oxygen therapy (HBOT), its primary function is not tied to a specific clinical indication beyond delivering oxygen to targeted tissues in a controlled, portable environment. It is designed for localized treatment applications, making it useful in settings where enhanced oxygen delivery to extremities or small areas is beneficial.

  • Is this device intended for single-use or repeated use, and what does that mean for its practical application in a clinical setting?

    The device is explicitly labeled as single-use only, meaning it is not designed for reuse after a single treatment session. This ensures sterility and safety for patients, as it eliminates the need for cleaning or reprocessing between uses. Clinicians should treat it as a disposable item, discarding it after one use to maintain compliance with medical device regulations and infection control protocols.

  • How is this hyperbaric oxygen chamber supplied, and are there any specific storage requirements mentioned in the documentation?

    The device is supplied as a disposable unit, meaning it comes pre-packaged and ready for immediate use without additional preparation. While the provided data does not specify detailed storage requirements (such as temperature or humidity controls), standard medical device storage practices—like keeping it in a clean, dry environment away from direct sunlight—should be followed. Since it is single-use, proper inventory management is key to ensuring availability when needed.

  • What regulatory pathway was followed for this device’s clearance, and what does that mean for its use in clinical practice?

    This device was cleared through the FDA 510(k) process (K840817), specifically under the Traditional 510(k) pathway, with a Substantially Equivalent (SESE) determination. This means it was compared to a legally marketed predicate device and deemed to have the same intended use and technological characteristics. Clinically, this clearance confirms it meets FDA safety and effectiveness standards for its designated use in hyperbaric oxygen therapy, though its application remains within the scope of topical/extremity oxygen delivery as defined in regulatory nomenclature.